CAS 2367004-54-2

Zanzalintinib

CAS: 2367004-54-2

Fórmula: C₂₉H₂₅FN₄O₅

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 528.5310

Ref: IN-DA01V4U8

XL092

CAS: 2367004-54-2

XL092

Pureza: ≥98%

Peso molecular: 528.53g/mol

Ref: 54-BUP09828

Zanzalintinib

CAS: 2367004-54-2

Fórmula: C₂₉H₂₅FN₄O₅

Peso molecular: 528.54

Ref: 4Z-Z-064001

XL092

CAS: 2367004-54-2

XL092 (JUN04542) is an Axl Mer cMet KDR inhibitor for the treatment of Axl and Mer receptor tyrosine kinase- dependent disorders.

Fórmula: C₂₉H₂₅FN₄O₅

Pureza: 98.60%

Cor e Forma: Solid

Peso molecular: 528.53

Ref: TM-T9052

Zanzalintinib

CAS: 2367004-54-2

Zanzalintinib is an ion channel inhibitor that blocks the activity of voltage-gated sodium channels. It is a potent and selective inhibitor of HER2 (human epidermal growth factor receptor 2) with IC50 values of 1.8 nM and 4.7 nM, respectively. Zanzalintinib has been used as a research tool to study protein interactions, such as interactions between HER2 and its ligands or other proteins in the cell. Zanzalintinib has also been shown to inhibit the proliferation of many cancer cells in vitro, including breast cancer cells, pancreatic cancer cells, colon cancer cells, and melanoma cells. This drug inhibits tumor growth by inhibiting angiogenesis through inhibition of vascular endothelial growth factor receptor-2 activation in vitro.
Zanzalintinib has high purity and can be obtained at 98% pure from Sigma-Aldrich Corp., St Louis MO 63178 USA or other manufacturers listed below

Fórmula: C₂₉H₂₅FN₄O₅

Pureza: Min. 95%

Peso molecular: 528.5 g/mol

Ref: 3D-SUD00454